Household contacts only need to self-isolate for 7 days from when the diagnosed person took the test, rather than 7 days from last contact with the diagnosed person,
Household contacts are not obligated to self-isolate more than once in a 21 day period
A person who had COVID-19 and becomes a close or household contact does not need to self-isolate if less than 8 weeks since the person finished their self-isolation period
Updating the provisions relating to medical clearance to align with recent amendments to the Public Health (COVID-19 Care Services) Order (No 3) so that a medical clearance certificate operates as a 6 week exemption to the booster requirement as well as the requirement to have 2 doses of the vaccine.
If your practice has an excess of COVID-19 vaccines, please notify CESPHN (email@example.com) as we may be able to help coordinate a transfer of the stock ideally two week prior to thaw use by date.
You should also notify the Vaccine Operations Centre (VOC) firstname.lastname@example.org of your excess doses so that they may be able to facilitate transfers outside the CESPHN region. Please note in the email to VOC that you have already contacted CESPHN.
Excess vaccine and AIR COVID-19 booster report
The AIR042A report has undergone enhancements. Using the practice’s PIP ID (Practice Incentives Program ID), providers can now identify all patients due for a booster vaccine.
Practices are strongly encouraged to recall all patients due for their booster vaccine and utilise their excess COVID-19 vaccines prior to defrost expiry.
In the event that your vaccines cannot be transferred/relocated with support from the PHN or VOC and your vaccines expire/pass their use by date, please see information on our website about disposal of COVID-19 vaccines.
4th dose of COVID-19 vaccine for severe immunocompromised patients
GPs are being asked to review patients and consider eligibility for 4th dose for any immunocompromised residents. A primary course of booster doses is defined as 3 doses of a COVID-19 vaccine, as recommended by ATAGI for people with severe immunocompromise.
Severely immunocompromised individuals 16 years and above who have received a third dose of a primary COVID-19 vaccine, are also recommended to receive a booster dose 3 months after the third primary dose, in line with the timing for the general population, For more information: ATAGI recommendations on the use of a booster dose of COVID-19 vaccine.
Should my child get a COVID-19 vaccine?
A new tool is now available to help parents make a decision about getting a COVID-19 vaccine for their children aged 5 to 15 years. Through five simple steps, the COVID-19 vaccine decision aid for children offers information to help parents and carers weigh up the risks and benefits of COVID-19 vaccination for their children. This tool could be helpful during consultations with patients to support discussions about COVID-19 vaccination in children. See also COVID-19 vaccine decision aid (16+ years).
COVID-19 Vaccination Training Package
Consumers Health Forum has developed a new training package to support vaccination providers to have meaningful conversations with patients considering COVID-19 vaccination. To access the training package, and order resources for your practice visit the Consumers Health Forum of Australia website. If you have any questions, please email email@example.com
Below are the latest multilingual resources available on the NSW Health website.
A reminder to check HealthPathways regularly for the latest updates on caring for COVID positive patients in the community. These have been updated to include information on the new oral antiviral treatments.
Some people in our community may not be able to access a GP or vaccination hub to receive a COVID-19 vaccination.
The CESPHN Vax at Home Service is ONLY for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster (their carers will also be able to be vaccinated).
The Vax at Home Service will accept referrals for people 16 years and over. For children 12-16 years with special circumstances and may require further support, referrals will be reviewed on a case by case basis.
Patient self-referrals will NOT be accepted. Patients should speak with their GP for a referral to this program if appropriate. Referrals will be accepted from general practitioners and from Local Health Districts.
Referrals MUST be sent through this Vax at Home Service Online Form – for people who are housebound and reside in the Sydney Local Health District or South Eastern Sydney Local Health District regions.
To order PPE for your practice or pharmacy click here. Distribution of pulse oximeters to patients identified as high risk is occurring via local health districts. CESPHN has access to a small supply of pulse oximeters.
GPs with patients they believe require a pulse oximeter urgently are asked to email firstname.lastname@example.org with their name and address and the PHN will arrange delivery of an oximeter. Practices actively seeing moderate risk COVID positive patients can also be sent up to five pulse oximeters.
Please note: new ordering and delivery process
CESPHN has supplied PPE to general practices, community pharmacies and allied health via the Commonwealth’s National Medical Stockpile over the course of the COVID-19 pandemic. However such supply was in response to normal PPE supply lines being disrupted by the pandemic.
The Commonwealth is commencing a more streamlined approach to Personal Protective Equipment (PPE) and pulse oximeter ordering, distribution and delivery.
The new process will commence in the next 4 weeks:
PPE deliveries will be delivered directly from the National Medical Stockpile (NMS) to general practitioners and immunising pharmacists (rather than via PHN)
Orders will still occur via CESPHN through an updated online request form
The Living with COVID PPE Bundle is intended to supply each practitioner with a 1 month supply of PPE (equivalent to 40 patient visits). If practitioners have a higher case load (i.e., over 40 patients), bundles can be ordered more frequently.
PPE Bundle: GPs, ACCHSs and GPRCs willing to manage COVID positive patients face-to-face, until 30 June 2022
Access to P2/N95 masks and eye protection: GPs and GPRCs willing to support COVID positive people virtually, and respiratory patients face-to-face until 31 March 2022 .
There will be a transition phase over the next 4 weeks while CESPHN manages and monitors current stock levels. The current request for PPE form on the CESPHN website will be updated to reflect the new process.
There will be some further requirements needed for ordering through this new process – please note so you can prepare:
Provider numbers for GPs ordering will be required
Sizes will be required for masks and gloves ordered for each practitioner
You must agree that the details provided in the order form are true and accurate, and all eligible requirements have been met
Ensure that consent has been obtained from each eligible practitioner for the collection, use and disclosure of personal information to the PHN, Logistics and Distribution Partners, and to Australian Department of Health for ordering, auditing and delivery purposes.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…